Systematic reviews as a tool for planning and interpreting trials

被引:9
作者
Bath, Philip M. W. [1 ]
Gray, Laura J. [1 ]
机构
[1] Univ Nottingham, Div Stroke Med, Stroke Trials Unit, Nottingham NG5 1PB, England
关键词
clinical trials; epidemiology; meta-analysis; stroke; ACUTE ISCHEMIC-STROKE; INDIVIDUAL PATIENT DATA; ORDINAL OUTCOMES; VASCULAR EVENTS; BLOOD-PRESSURE; INFARCT SIZE; METAANALYSIS; PREVENTION;
D O I
10.1111/j.1747-4949.2009.00235.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Systematic reviews followed by a meta-analysis are carried out in medical research to combine the results of two or more related studies. Stroke trials have struggled to show beneficial effects and meta-analysis should be used more widely throughout the research process to either speed up the development of useful interventions, or halt more quickly research with hazardous or ineffective interventions. This review summarises the clinical research process and illustrates how and when systematic reviews may be used throughout the development programme. Meta-analyses should be performed after observational studies, preclinical studies in experimental stroke, and after phase I, II, and III clinical trials and phase IV clinical surveillance studies. Although meta-analyses most commonly work with summary data, they may be performed to assess relationships between variables (meta-regression) and, ideally, should utilise individual patient data. Meta-analysis techniques may also work with ordered categorical outcome data (ordinal meta-analysis) and be used to perform indirect comparisons where original trial data do not exist. Systematic review/meta-analyses are powerful tools in medical research and should be used throughout the development of all stroke and other interventions.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 40 条
[1]   Emergency administration of abciximab for treatment of patients with acute ischemic stroke:: Results of an international phase III trial -: Abciximab in emergency treatment of stroke trial (AbESTT-II) [J].
Adams, Harold P., Jr. ;
Effron, Mark B. ;
Torner, James ;
Davalos, Antoni ;
Frayne, Judith ;
Teal, Philip ;
Leclerc, Jacques ;
Oemar, Barry ;
Padgett, Lakshmi ;
Barnathan, Elliot S. ;
Hacke, Werner .
STROKE, 2008, 39 (01) :87-99
[2]   Emergency administration of abciximab for treatment of patients with acute ischemic stroke -: Results of a randomized phase 2 trial [J].
Adams, HP ;
Hacke, W ;
Oemar, B ;
Dávalos, A ;
Cook, RA ;
Trouillas, P ;
Fazekas, F ;
Bogousslavsky, J ;
Hilburn, J ;
Torner, J ;
Leclerc, J ;
Shuaib, A ;
Reid, P .
STROKE, 2005, 36 (04) :880-890
[3]  
Adams HP, 2000, STROKE, V31, P601
[4]  
[Anonymous], COCHRANE DATABASE SY
[5]  
Bath P.M., 2001, COCHRANE DB SYST REV
[6]   Use of ordinal outcomes in vascular prevention trials - Comparison with binary outcomes in published trials [J].
Bath, Philip M. W. ;
Geeganage, Chamila ;
Gray, Laura J. ;
Collier, Timothy ;
Pocock, Stuart .
STROKE, 2008, 39 (10) :2817-2823
[7]   Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials [J].
Bath, Philip M. W. .
STROKE, 2007, 38 (06) :1911-1915
[8]   Low-molecular-weight heparins and heparinoids in acute ischemic stroke - A meta-analysis of randomized controlled trials [J].
Bath, PMW ;
Iddenden, R ;
Bath, FJ .
STROKE, 2000, 31 (07) :1770-1778
[9]   Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial [J].
Bath, PMW ;
Lindenstrom, E ;
Boysen, G ;
De Deyn, P ;
Friis, P ;
Leys, D ;
Marttila, R ;
Olsson, JE ;
O'Neill, D ;
Orgogozo, JM ;
Ringelstein, B ;
van der Sande, JJ ;
Turpie, AGG .
LANCET, 2001, 358 (9283) :702-710
[10]  
BATH PMW, 2004, COCHRANE DATABASE SY